In-depth analyses, mechanism reviews, and evidence summaries for researchers and informed individuals. All articles link to peer-reviewed sources.
BPC-157 and TB-500 represent two distinct but complementary mechanisms for tissue repair. BPC-157 acts locally through the FAK-paxillin pathway, while TB-500 provides systemic healing via actin regulation. This analysis examines their mechanisms, research applications, and synergistic potential.
The GLP-1 agonist class has transformed metabolic research. With semaglutide, tirzepatide, and the emerging triple-agonist retatrutide now under study, researchers have an expanding toolkit. This guide compares mechanisms, efficacy data, and research profiles across all three.
The combination of CJC-1295 (GHRH analog) and Ipamorelin (GHRP) is considered the gold standard for GH optimization in research settings. This analysis examines the pharmacokinetics, synergistic mechanisms, and research outcomes of this widely-studied protocol.
Epithalon's ability to activate telomerase and elongate telomeres has made it one of the most studied longevity peptides. This article examines the science of telomere biology, Khavinson's 35+ years of research, and the implications for anti-aging science.
Russia's contribution to nootropic peptide research has produced two of the most studied cognitive enhancers: Selank and Semax. Both have undergone clinical trials and are approved in Russia for anxiety and cognitive disorders respectively.
Thymosin Alpha-1 (Tα1) has the most extensive validation of any immunomodulatory peptide, with approval in 35+ countries. This review covers its mechanisms, applications from hepatitis to COVID-19 research, and its role in modern immune optimization protocols.
GHK-Cu's ability to modulate gene expression on a massive scale has made it one of the most fascinating peptides in longevity research. Loren Pickart's decades of research reveal a peptide that may be central to the body's wound healing and anti-aging response.
The peptide research space exists in a complex regulatory environment. This guide helps researchers understand FDA classifications, USADA warnings, compounding pharmacy regulations, and evidence-based risk assessment for peptide protocols.
NAD+ precursors and the mitochondria-derived peptide MOTS-c represent a new frontier in metabolic and longevity research. This article examines how these molecules interact with sirtuins, AMPK pathways, and mitochondrial biogenesis to influence aging and metabolic health.
PT-141 (bremelanotide) and Kisspeptin represent two distinct but complementary approaches to sexual health research. PT-141 acts centrally via melanocortin receptors, while Kisspeptin modulates the HPG axis. This review examines their mechanisms and research profiles.
Both Sermorelin and Tesamorelin are synthetic GHRH analogs that stimulate endogenous GH release, but they differ significantly in half-life, potency, and research applications. This comparison examines their pharmacological profiles and research use cases.
KPV (Lys-Pro-Val) is a C-terminal fragment of alpha-MSH with potent anti-inflammatory properties in the gut. Larazotide acetate (AT-1001) is a tight junction regulator studied in celiac disease. Together, they represent a new approach to gut barrier research.
Dihexa (PNB-0408) is a potent hepatocyte growth factor (HGF) potentiator that promotes synaptogenesis. Noopept is a synthetic dipeptide derived from piracetam with BDNF and NGF-upregulating properties. This review examines their mechanisms and research applications.
Melanotan II is a synthetic analog of alpha-MSH with effects on pigmentation, sexual function, and appetite. Oxytocin, the "bonding hormone," has been studied for social behavior, anxiety, and metabolic effects. This article reviews their research profiles and mechanisms.
5-Amino-1MQ is a small molecule NNMT inhibitor that activates metabolic pathways similar to caloric restriction. SLU-PP-332 is an ERRα/γ agonist that mimics the effects of exercise at the molecular level. Both represent cutting-edge metabolic research compounds.
Delta Sleep-Inducing Peptide (DSIP) was first isolated from rabbit cerebral venous blood during slow-wave sleep. This review examines DSIP's mechanisms, its interaction with the HPA axis, and the broader science of peptide-mediated sleep regulation including the AEDG peptide.
Cagrilintide is a long-acting amylin analog developed by Novo Nordisk, currently in Phase 3 trials in combination with semaglutide (CagriSema). This article examines amylin biology, cagrilintide's mechanism, and the emerging dual-hormone approach to metabolic research.
Members-Only Access
Access advanced peptide education, protocol insights, and research-based information curated for informed users. Create a free account or log in to continue.
Please acknowledge the disclaimer above to continue.